Defects in these genes are associated with various clinical conditions including obesity, type-2 diabetes (ADRB2), citrullinemia (SLC25A13), Tangier disease and systemic amyloidosis (APOA1) [21–24]. This evidence concerns the gene APOA1 and obesity disorder.